Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced its business update and financial results for the first nine months of 2025. "This quarter highlights ...
At the start of each recording session for his new EP, Leon Thomas spent time messing around with various instruments. Then, ...
You're guaranteed to leave with a natural and healthy glow with the JLo Hydrafacial treatment, now available at the Mandarin ...
New clinical research has identified a blood test that can reveal which women are more likely to respond to a particular ...
Q3 2025 revenue of €143.1 million for YORVIPATH® and €50.7 million for SKYTROFA®– Q3 2025 operating profit of €11.0 million– TransCon® ...
Causeway Bay, HK – November 10, 2025 – PRESSADVANTAGE – Ginza Diamond Shiraishi Hong Kong has released new observations on ...
News-Medical.Net on MSN
Simple blood test may be a better guide treatment for ovarian cancer
The team's results, published in Nature Communications, reveal that the RMIT-patented biomarkers – easily identified through a simple blood test – may be a better guide to who'll potentially benefit ...
Zelenectide pevedotin (BT8009) demonstrated a well-tolerated safety profile and promising antitumor activity in patients with ...
If you’ve ever seen silver tresses gleaming like moonlight, one of the best glosses for gray hair may have had a hand in that ...
Q3 2025 Earnings Call Transcript November 10, 2025 Compugen Ltd. beats earnings expectations. Reported EPS is $-0.07461, ...
Asharq Al-Awsat on MSN
Gilead's Breast Cancer Drug Fails to Meet Main Goal of Late-stage Study
Gilead Sciences said on Friday its breast cancer drug Trodelvy did not significantly lower the risk of disease progression in ...
From November 6 to 9, the 2025 Chinese Congress on Holistic Integrative Oncology (CCHIO) was held in Kunming, Yunnan. This conference was jointly organized by the Chinese Anti-Cancer Association (CACA ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果